To include your compound in the COVID-19 Resource Center, submit it here.

Aclaris raises $20M in private placement

Aclaris Therapeutics Inc. (NASDAQ:ACRS) raised $20 million through the sale of 1.1 million shares at $18.50 in a

Read the full 183 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE